Publications by authors named "Clement Hoguin"

Claim this Profile
gain-of-function mutation in Schwann cells leads to severe neuropathy and aerobic glycolysis through a non-cell autonomous effect.
Quitterie Venot, Marina Firpion, Sophia Ladraa, Charles Bayard, Sato Magassa, Clément Hoguin

Proc Natl Acad Sci U S A· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib for Vascular Malformations Associated with G12C Mutation.
Antoine Fraissenon, Charles Bayard, Gabriel Morin, Sandro Benichi, Clément Hoguin

N Engl J Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis.
Junna Yamaguchi, Pierre Isnard, Noémie Robil, Pierre de la Grange, Clément Hoguin

J Clin Invest· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy for capillary-venous malformations.
Lola Zerbib, Sophia Ladraa, Antoine Fraissenon, Charles Bayard, Marina Firpion, Clément Hoguin

Signal Transduct Target Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition.
Charles Bayard, Eleonora Segna, Maxime Taverne, Antoine Fraissenon, Quentin Hennocq, Clément Hoguin

J Exp Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption.
Sophia Ladraa, Lola Zerbib, Charles Bayard, Antoine Fraissenon, Quitterie Venot, Clément Hoguin

Sci Adv· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib.
Gabriel Morin, Caroline Degrugillier-Chopinet, Marie Vincent, Antoine Fraissenon, Hélène Aubert, Clément Hoguin

J Exp Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpelisib administration reduced lymphatic malformations in a mouse model and in patients.
Florence Delestre, Quitterie Venot, Charles Bayard, Antoine Fraissenon, Sophia Ladraa, Clément Hoguin

Sci Transl Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REST and Stress Resistance in the Aging Kidney.
Sato Magassa, Liviu Aron, Clément Hoguin, Pierre Isnard, Fabiola Terzi

J Am Soc Nephrol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome.
Quitterie Venot, Thomas Blanc, Smail Hadj Rabia, Laureline Berteloot, Sophia Ladraa, Clément Hoguin

Nature· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy in patients with PIK3CA-related overgrowth syndrome.
Quitterie Venot, Thomas Blanc, Smail Hadj Rabia, Laureline Berteloot, Sophia Ladraa, Clément Hoguin

Nature· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis